Hims & Hers Health closed at $24.06 on Nov 5, down 9.75%, 45.0% below its 52-week closing high. Volume of 17.6M shares was 1.72× its 20-day average (above normal).
Split-adjusted performance: -18.6% over one month, -6.2% over six months, -43.8% over one year.
In the quarter ended Jun 30, 2026, revenue was $753.21M, up 38.2% from a year earlier, with a net margin of -11.5%.
Short interest was 53.5M shares at the Oct 15 settlement, down 2.4% from the prior report (26.2% of float, 5.0 days to cover).